Ketan Shah has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ketan Shah, on behalf of the promoter group and persons acting in concert, has filed an annual disclosure with NSE and BSE under SEBI Takeover Regulations. He confirmed that the promoter group collectively holds 76,18,760 equity shares of Biofil Chemicals & Pharmaceuticals as on March 31, 2025. He further declared that no encumbrance (pledge or similar charge) was created on any of these shares, directly or indirectly, during the financial year. This is a routine annual compliance filing required from promoter group members.
This is a neutral, routine compliance filing with no change in promoter shareholding or pledge status, so it is unlikely to have any meaningful impact on the stock price or shareholder sentiment.